0001193125-13-007836.txt : 20130109 0001193125-13-007836.hdr.sgml : 20130109 20130109112034 ACCESSION NUMBER: 0001193125-13-007836 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130109 DATE AS OF CHANGE: 20130109 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Dermaxar Inc. CENTRAL INDEX KEY: 0001125918 STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840] IRS NUMBER: 980547993 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80555 FILM NUMBER: 13519860 BUSINESS ADDRESS: STREET 1: 67 MOWAT AVENUE, SUITE 535 CITY: TORONTO STATE: A6 ZIP: M6K 3E3 BUSINESS PHONE: 416.657.3456 MAIL ADDRESS: STREET 1: 67 MOWAT AVENUE, SUITE 535 CITY: TORONTO STATE: A6 ZIP: M6K 3E3 FORMER COMPANY: FORMER CONFORMED NAME: Euoko Group Inc. DATE OF NAME CHANGE: 20080118 FORMER COMPANY: FORMER CONFORMED NAME: Euoko, Inc. DATE OF NAME CHANGE: 20070525 FORMER COMPANY: FORMER CONFORMED NAME: VITA EQUITY INC DATE OF NAME CHANGE: 20001005 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KNIGHT CAPITAL AMERICAS LLC CENTRAL INDEX KEY: 0001457716 IRS NUMBER: 264219373 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 545 WASHINGTON BLVD. CITY: JERSEY CITY STATE: NJ ZIP: 07310 BUSINESS PHONE: 201-356-1705 MAIL ADDRESS: STREET 1: 545 WASHINGTON BLVD. CITY: JERSEY CITY STATE: NJ ZIP: 07310 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT EXECUTION & CLEARING SERVICES LLC DATE OF NAME CHANGE: 20120711 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT CAPITAL AMERICAS LLC DATE OF NAME CHANGE: 20120710 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT EXECUTION & CLEARING SERVICES LLC DATE OF NAME CHANGE: 20120710 SC 13G/A 1 d464861dsc13ga.htm AMENDMENT NO. 1 TO SCHEDULE 13G Amendment No. 1 to Schedule 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Schedule 13G/A

(Amendment 1)

Under the Securities Exchange Act of 1934

 

 

Dermaxar INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

24983W100

(CUSIP Number)

December 31, 2012

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13G/A

 

CUSIP NO. 24983W100  

 

  1.   

NAME OF REPORTING PERSON

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)

 

Knight Capital Americas, LLC

22-3660471

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨        (b)  ¨

 

  3.  

SEC USE ONLY

 

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

   5.    

SOLE VOTING POWER

 

    470,817

   6.   

SHARED VOTING POWER

 

    Not applicable

   7.   

SOLE DISPOSITIVE POWER

 

    470,817

   8.   

SHARED DISPOSITIVE POWER

 

    Not applicable

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    470,817

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

8.05% based on outstanding shares reported in the issuer’s 1/14/2011 8K filed with the SEC.

12.  

TYPE OF REPORTING PERSON*

 

    BD


ITEM 1  

(a).

   Name of Issuer      
     Dermaxar INC.      
ITEM 1  

(b).

   Address of Issuer’s Principal Executive Offices      
     314-837 West Hastings Street, Vancouver, BC V6C 3N6, Canada      
ITEM 2  

(a).

   Names of Persons Filing      
     Knight Capital Americas, LLC      
ITEM 2  

(b).

   Address of principal business office      
    

545 Washington Blvd., 3rd Floor

Jersey City, NJ 07310

     
ITEM 2  

(c).

   Citizenship      
     Delaware      
ITEM 2  

(d).

   Title of Class of Securities      
     Common Stock      
ITEM 2  

(e).

   CUSIP Number      
     24983W100      
ITEM 3.   If this statement is filed pursuant to Rules 13d-1(b), or 13(d)-2(b), check whether the person filing it is a:   
  (a)    x    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).


ITEM 4.    Ownership      
   (a)    Amount beneficially owned      
      470,817      
   (b)    Percent of class      
      8.05%      
   (c)    Number of shares as to which such person has:      
      (i)    sole power to vote or to direct the vote      
         470,817      
      (ii)    shared power to vote or to direct the vote      
         Not applicable      
      (iii)    sole power to dispose or to direct the disposition of      
         470,817      
      (iv)    shared power to dispose or to direct the disposition of      
         Not applicable      
ITEM 5.    Ownership of Five Percent or Less of a Class   
   Not applicable   
ITEM 6.    Ownership of More than Five Percent on Behalf of Another Person      
   Not applicable      
ITEM 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
   Not applicable.
ITEM 8.    Identification and Classification of Members of the Group      
   Not applicable.      
ITEM 9.    Notice of Dissolution of Group      
   Not applicable.      
ITEM 10.    Certification      
   By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.      
   After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.      

Date: January 8, 2013

 

Knight Capital Americas, LLC
By:  

/s/ Michael Corrao

  Michael Corrao
  Director of Compliance